Kevin Fischbeck
Stock Analyst at B of A Securities
(4.01)
# 534
Out of 5,146 analysts
188
Total ratings
64.39%
Success rate
6.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPCH Option Care Health | Maintains: Buy | $32 → $35 | $31.89 | +9.75% | 2 | Dec 9, 2025 | |
| ACHC Acadia Healthcare Company | Downgrades: Underperform | $22 → $13 | $22.29 | -41.68% | 9 | Dec 3, 2025 | |
| ARDT Ardent Health | Maintains: Underperform | $12 → $10 | $9.48 | +5.49% | 4 | Nov 13, 2025 | |
| HUM Humana | Maintains: Neutral | $280 → $300 | $186.83 | +60.57% | 17 | Oct 10, 2025 | |
| ELV Elevance Health | Maintains: Neutral | $330 → $370 | $323.05 | +14.53% | 4 | Oct 10, 2025 | |
| UNH UnitedHealth Group | Maintains: Neutral | $350 → $390 | $286.66 | +36.05% | 27 | Oct 8, 2025 | |
| AMN AMN Healthcare Services | Maintains: Underperform | $20 → $18 | $19.14 | -5.96% | 5 | Sep 10, 2025 | |
| DVA DaVita | Maintains: Underperform | $145 → $140 | $152.54 | -8.22% | 13 | Sep 10, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $205 → $225 | $239.67 | -6.12% | 8 | Sep 10, 2025 | |
| EHC Encompass Health | Maintains: Buy | $145 → $160 | $107.20 | +49.25% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $30 | $42.93 | -30.12% | 13 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $215 → $185 | $204.33 | -9.46% | 15 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $394 → $410 | $525.88 | -22.04% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $3 | $0.59 | +404.54% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $146.36 | +199.95% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $9.08 | -28.41% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $20.42 | -64.50% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $288.82 | +21.18% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $15.37 | +192.78% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.66 | +50.27% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $14.92 | +134.58% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $2.15 | +365.12% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $8.77 | -14.48% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $19.86 | - | 3 | Sep 6, 2019 |
Option Care Health
Dec 9, 2025
Maintains: Buy
Price Target: $32 → $35
Current: $31.89
Upside: +9.75%
Acadia Healthcare Company
Dec 3, 2025
Downgrades: Underperform
Price Target: $22 → $13
Current: $22.29
Upside: -41.68%
Ardent Health
Nov 13, 2025
Maintains: Underperform
Price Target: $12 → $10
Current: $9.48
Upside: +5.49%
Humana
Oct 10, 2025
Maintains: Neutral
Price Target: $280 → $300
Current: $186.83
Upside: +60.57%
Elevance Health
Oct 10, 2025
Maintains: Neutral
Price Target: $330 → $370
Current: $323.05
Upside: +14.53%
UnitedHealth Group
Oct 8, 2025
Maintains: Neutral
Price Target: $350 → $390
Current: $286.66
Upside: +36.05%
AMN Healthcare Services
Sep 10, 2025
Maintains: Underperform
Price Target: $20 → $18
Current: $19.14
Upside: -5.96%
DaVita
Sep 10, 2025
Maintains: Underperform
Price Target: $145 → $140
Current: $152.54
Upside: -8.22%
Tenet Healthcare
Sep 10, 2025
Maintains: Buy
Price Target: $205 → $225
Current: $239.67
Upside: -6.12%
Encompass Health
Sep 10, 2025
Maintains: Buy
Price Target: $145 → $160
Current: $107.20
Upside: +49.25%
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $42.93
Upside: -30.12%
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $204.33
Upside: -9.46%
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $525.88
Upside: -22.04%
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $0.59
Upside: +404.54%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $146.36
Upside: +199.95%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $9.08
Upside: -28.41%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $20.42
Upside: -64.50%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $288.82
Upside: +21.18%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $15.37
Upside: +192.78%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.66
Upside: +50.27%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $14.92
Upside: +134.58%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $2.15
Upside: +365.12%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $8.77
Upside: -14.48%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $19.86
Upside: -